221 related articles for article (PubMed ID: 6445604)
1. Antithrombotic therapy for vascular prosthesis: an experimental model testing platelet inhibitory drugs.
McCollum CN; Crow MJ; Rajah SM; Kester RC
Surgery; 1980 Jun; 87(6):668-76. PubMed ID: 6445604
[TBL] [Abstract][Full Text] [Related]
2. The thrombogenicity of Dacron arterial grafts and its modification by platelet inhibitory drugs.
Kester RC
Ann R Coll Surg Engl; 1984 Jul; 66(4):241-6. PubMed ID: 6234841
[TBL] [Abstract][Full Text] [Related]
3. Aspirin and dipyridamole reduce platelet deposition on prosthetic femoro-popliteal grafts in man.
Goldman MD; Simpson D; Hawker RJ; Norcott HC; McCollum CN
Ann Surg; 1983 Dec; 198(6):713-6. PubMed ID: 6227296
[TBL] [Abstract][Full Text] [Related]
4. Effects of acetylsalicylic acid, sulfinpyrazone and dipyridamole on platelet adhesion and aggregation in flowing native and anticoagulated blood.
Baumgartner HR
Haemostasis; 1979; 8(3-5):340-52. PubMed ID: 511014
[TBL] [Abstract][Full Text] [Related]
5. Platelet inhibitory drugs: an in vivo method of evaluation in patients.
Norcott HC; Goldman M; Hawker RJ; Rafiqi EI; Drolc Z; McCollum CN
Thromb Haemost; 1982 Dec; 48(3):307-10. PubMed ID: 6761890
[TBL] [Abstract][Full Text] [Related]
6. Effects of very low versus standard dose acetyl salicylic acid, dipyridamole and sulfinpyrazone on platelet function and thromboxane formation in man.
Lorenz R; Siess W; Weber PC
Eur J Pharmacol; 1981 Apr; 70(4):511-8. PubMed ID: 7238575
[TBL] [Abstract][Full Text] [Related]
7. Prevention of platelet aggregation and adherence to prosthetic vascular grafts by aspirin and dipyridamole.
Oblath RW; Buckley FO; Green RM; Schwartz SI; DeWeese JA
Surgery; 1978 Jul; 84(1):37-44. PubMed ID: 149385
[No Abstract] [Full Text] [Related]
8. Aspirin and other platelet-aggregation inhibiting drugs.
Gallus AS
Med J Aust; 1985 Jan; 142(1):41-7. PubMed ID: 3880861
[TBL] [Abstract][Full Text] [Related]
9. The effect of platelet function inhibitors on experimental venous thrombosis formation in rabbits.
Arfors KE; Bergqvist D; Tangen O
Acta Chir Scand; 1975; 141(1):40-2. PubMed ID: 1092111
[TBL] [Abstract][Full Text] [Related]
10. Effects of platelet-modifying drugs on arterial thromboembolism in baboons. Aspirin potentiates the antithrombotic actions of dipyridamole and sulfinpyrazone by mechanism(s) independent of platelet cyclooxygenase inhibition.
Hanson SR; Harker LA; Bjornsson TD
J Clin Invest; 1985 May; 75(5):1591-9. PubMed ID: 3923041
[TBL] [Abstract][Full Text] [Related]
11. Prevention of platelet deposition and thrombus formation on hemodialysis membranes: a double-blind randomized trial of aspirin and dipyridamole.
Salter MC; Crow MJ; Donaldson DR; Roberts TG; Rajah SM; Davison AM
Artif Organs; 1984 Feb; 8(1):57-61. PubMed ID: 6703927
[TBL] [Abstract][Full Text] [Related]
12. Enhanced antiplatelet effects of clopidogrel plus acetylsalicylic acid compared with acetylsalicylic acid alone or combined with extended-release dipyridamole in healthy volunteers.
Caplain H
Cerebrovasc Dis; 2005; 19(4):214-9. PubMed ID: 15703464
[TBL] [Abstract][Full Text] [Related]
13. Superior efficacy of clopidogrel plus acetylsalicylic acid compared with extended-release dipyridamole plus acetylsalicylic acid in preventing arterial thrombogenesis in healthy volunteers.
Cadroy Y; Thalamas C; Sakariassen K; Boneu B
Thromb Res; 2005; 116(4):293-300. PubMed ID: 16038713
[TBL] [Abstract][Full Text] [Related]
14. Effects of dipyridamole and low-dose aspirin therapy on platelet adhesion to vascular subendothelium.
Lauri D; Zanetti A; Dejana E; de Gaetano G
Am J Cardiol; 1986 Dec; 58(13):1261-4. PubMed ID: 3788816
[TBL] [Abstract][Full Text] [Related]
15. [Action mechanism and clinical indications for thrombocyte aggregation inhibitors].
Oelz O
Schweiz Med Wochenschr; 1979 Mar; 109(10):348-53. PubMed ID: 424707
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of the thrombogenic potential of three types of arterial graft studied in an artificial circulation.
Hamlin GW; Rajah SM; Crow MJ; Kester RC
Br J Surg; 1978 Apr; 65(4):272-6. PubMed ID: 147719
[TBL] [Abstract][Full Text] [Related]
17. The influence of red blood cells on the effects of aspirin or sulphinpyrazone on platelet adherence to damaged rabbit aorta.
Davies JA; Essien E; Cazenave JP; Kinlough-Rathbone RL; Gent M; Mustard JF
Br J Haematol; 1979 Jun; 42(2):283-91. PubMed ID: 465372
[TBL] [Abstract][Full Text] [Related]
18. In vivo quantitation of platelet deposition on human peripheral arterial bypass grafts using indium-111-labeled platelets. Effect of dipyridamole and aspirin.
Pumphrey CW; Chesebro JH; Dewanjee MK; Wahner HW; Hollier LH; Pairolero PC; Fuster V
Am J Cardiol; 1983 Mar; 51(5):796-801. PubMed ID: 6219569
[TBL] [Abstract][Full Text] [Related]
19. Antiplatelet agents: rationale and results.
Kelton JG
Clin Haematol; 1983 Feb; 12(1):311-54. PubMed ID: 6132693
[No Abstract] [Full Text] [Related]
20. Effects of a novel platelet nitric oxide donor (LA816), aspirin, clopidogrel, and combined therapy in inhibiting flow- and lesion-dependent thrombosis in the porcine ex vivo model.
Vilahur G; Segalés E; Salas E; Badimon L
Circulation; 2004 Sep; 110(12):1686-93. PubMed ID: 15381660
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
